Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better.

From the week of June 16th, we are planning to work on 16 projects, including:

Reimbursement

1. Delivering market access strategy for several technologies in ophthalmological, urological, and oncological fields in Belgium and the Netherlands
2. Delivering reimbursement analysis for diagnostic tests in the neurology area in Switzerland
3. Delivering reimbursement analysis for diagnostic tests in obstetric care in England, France, Germany, Italy, Spain, and Switzerland
4. Working on reimbursement analysis for the administration of a medication in outpatient settings in England, France, Germany, and Sweden
5. Working on reimbursement analysis for cardiovascular technology in several Italian regions
6. Working on reimbursement analysis for cardiovascular devices in Belgium
7. Working on a high-level overview of market access pathways for in-vitro diagnostics in England, France, Germany, Italy, and Spain
8. Initiating work on a high-level overview of market access pathways for in-vitro diagnostics in 11 European countries
9. Initiating work on reimbursement analysis for diagnostic tests in the neurology area in England, France, Germany, Italy, and Spain

HEOR

1. Delivering analysis of HTA requirements for surgical equipment in ten European countries
2. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
3. Working on the development of an early value dossier for wound treatment technology in European countries 
4. Working on the early health economic analysis for wound treatment in England
5. Working on a systematic review and meta-analysis for an in vitro diagnostic test
6. Initiating work on evidence gap analysis for in vitro diagnostic tests in the neurology area 
7. Initiating work on the development of a catalog of studies for in vitro diagnostic tests in the neurology area 

Let us know if you need any market access or HEOR support for your medical technology in Europe.